Effects of CP-060S, a novel Ca2+ channel blocker, on oxidative stress in cultured cardiac myocytes

被引:17
作者
Hara, A
Suzuki, T
Hashizume, H
Shishido, N
Nakamura, M
Ushikubi, F
Abiko, Y
机构
[1] Asahikawa Med Coll, Dept Pharmacol, Asahikawa, Hokkaido 0788510, Japan
[2] Univ Tokyo, Radiat Res Inst, Tokyo 1130033, Japan
[3] Asahikawa Med Coll, Dept Chem, Asahikawa, Hokkaido 0788510, Japan
关键词
anti-oxidant; Ca2+ channel blocker; cardiac myocyte; diltiazem; hydrogen peroxide;
D O I
10.1016/S0014-2999(99)00708-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of (-)-(S)-2-[3,5-bis(1,1-dimethylethyl)-4-hyroxyphenyl]-3-[3-[N-methyl-N-[2-(3,4-methylenedioxyphenoxy)-ethyl]amino]propyl]-1,3-thiazolidin-4-one hydrogen fumarate (CP-060S), a novel Ca2+ channel blocker, on hydrogen peroxide (H2O2)- induced cytotoxicity was studied in cultured rat cardiac myocytes. The CP-060S effect was compared with that of CP-060R, an optical isomer of CP-060S with a less potent Ca2+ channel blocking action than CP-060S. H2O2 increased the release of lactate dehydrogenase from cardiac myocytes and decreased the formation of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) (MTT) formazan in cardiac myocytes (i.e., cytotoxic action). Both CP-060S (1 mu M) and CP-060R (1 mu M) attenuated to a similar extent the foregoing alterations induced by H2O2. On the otherhand, 1,3-dimethyl-2-thiourea (10 mM), a scavenger of both H2O2 and hydroxyl radical, also attenuated the H2O2-induced cytotoxicity whereas diltiazem(10 mu M) did not. In an experiment using electron spin resonance (ESR) with 5,5-dimethyl-1-pyrroline N-oxide (DMPO), a spin-trapping agent, both CP-060S and CP-060R decreased the intensity of DMPO-hydroxyl radical signal concentration dependently. These results suggest that CP-060S protects cardiac myocytes from oxidative stress through its radical scavenging action. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 30 条
[22]   Metal-induced hydroxyl radical generation by Cu+-metallothioneins from LEC rat liver [J].
Nakamura, M ;
Nakayama, K ;
Shishido, N ;
Yumino, K ;
Ohyama, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 231 (03) :549-552
[23]   ELECTROPHYSIOLOGICAL DERANGEMENTS INDUCED BY LIPID-PEROXIDATION IN CARDIAC TISSUE [J].
NAKAYA, H ;
TOHSE, N ;
KANNO, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (05) :H1089-H1097
[24]   Effects of CP-060S on membrane channels in vascular smooth muscle cells from guinea pig [J].
Ohya, Y ;
Adachi, N ;
Setoguchi, M ;
Abe, I ;
Fujishima, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 330 (01) :93-99
[25]  
SLEZAK J, 1995, AM J PATHOL, V147, P772
[26]  
SUZUKI T, 1989, IN VITRO CELL DEV B, V25, P601
[27]   Purification of endothelin from a conditioned medium of cardiac fibroblastic cells using beating rate assay of myocytes cultured in a serum free medium [J].
Suzuki, T ;
Tsuruda, A ;
Katoh, S ;
Kubodera, A ;
Mitsui, Y .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (08) :2087-2093
[28]   CP-060S, a novel cardioprotective drug, limits myocardial infarct size in anesthetized dogs [J].
Suzuki, Y ;
Tamura, K ;
Akima, M ;
Adachi, Y ;
Fukazawa, M ;
Kato, T .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (03) :400-407
[29]   CP-060S interacts with three principal binding sites on the L-type Ca2+ channel [J].
Suzuki, Y ;
Tamura, K ;
Adachi, Y ;
Fukazawa, M ;
Kato, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 342 (2-3) :347-351
[30]   Actions of CP-060S on veratridine-induced Ca2+ overload in cardiomyocytes and mechanical activities in vascular strips [J].
Tamura, K ;
Suzuki, Y ;
Koga, T ;
Akima, M ;
Kato, T ;
Nabata, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 312 (02) :195-202